Stocks to Watch in Europe UBS, Next, Chipmakers - Bloomberg
TNBI Stock | USD 0.02 0.01 33.33% |
Under 60% of Tanke Biosciences' investor base is looking to short. The analysis of overall sentiment of trading Tanke Biosciences pink sheet suggests that many investors are alarmed at this time. Tanke Biosciences' investing sentiment shows overall attitude of investors towards Tanke Biosciences.
Tanke |
Stocks to Watch in Europe UBS, Next, Chipmakers Bloomberg
Read at news.google.com
Tanke Biosciences Fundamental Analysis
We analyze Tanke Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tanke Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tanke Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Asset
Return On Asset Comparative Analysis
Tanke Biosciences is currently under evaluation in return on asset category among its peers. Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Tanke Biosciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Tanke Biosciences pink sheet to make a market-neutral strategy. Peer analysis of Tanke Biosciences could also be used in its relative valuation, which is a method of valuing Tanke Biosciences by comparing valuation metrics with similar companies.
Peers
Tanke Biosciences Related Equities
AWCA | Awaysis Capital | 30.00 | ||||
ECGR | Bellatora | 6.67 |
Complementary Tools for Tanke Pink Sheet analysis
When running Tanke Biosciences' price analysis, check to measure Tanke Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tanke Biosciences is operating at the current time. Most of Tanke Biosciences' value examination focuses on studying past and present price action to predict the probability of Tanke Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tanke Biosciences' price. Additionally, you may evaluate how the addition of Tanke Biosciences to your portfolios can decrease your overall portfolio volatility.
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |